2-(4-Chlorophenoxy)-N,2-dimethyl-N-(2,3,4,5,6-pentahydroxyhexyl)propanamide, 250mg

5-Bromo-2-chloro-N4-ethylpyridine-3,4-diamine, 98%, 250mg

Objectif achromatique semi-plan DIN S100x NA 1,25

8-tert-Butyl 3-ethyl 2-oxo-8-azabicyclo[3.2.1]octane-3,8-dicarboxylate, 98%, 100mg

6,8-DIOXO-5,7-DIAZASPIRO[3.4]OCTANE-2-CARBOXYLIC ACID, 95.0%, 1g

3-(4-BROMOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOIC ACID, 95.0%, 250mg

6-BROMO-5-CHLOROQUINAZOLIN-2-AMINE, 95.0%, 250mg

2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3'-methoxy benzophenone, 97.0%, 1g

1-Cyclopropyl-2-methoxyethanamine hydrochloride, 95.0%, 250mg

4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide, 95.0%, 5g

4,5-Dibromo-3-methylisothiazole, 97%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)-2-methylpropanoic acid, 97%, 250mg

(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione, 98%, 1g